This morning it could be a good idea for investors to keep an eye on the Lotus Bio-Technology Development Corp (OTCMKTS:LBTD) stock following a key announcement from the company on Tuesday.
Trading Data
On Tuesday, LBTD stock ended flat at $0.0360 with 4.05K shares, compared to its average volume 46.54K shares. The stock moved within a range of $0.0360 – 0.0360 after opening trade at $0.0360.
Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC
The company came into focus on Tuesday after it announced that it had sold Boomerangkit.com LLC, it’s at-home diagnostic brand, to BioGnomics Lab LLC. BioGnomics is known for providing the highest class of medical testing solutions and is also certified by the CLIA. It was a major new development for the company and it is now going to be interesting to see if the sale of the brand leads to any moves in the Lotus Bio-Technology Development stock this morning or not.
However, that was not all. The company also announced that William McDonald was going to be inducted as a new director and he is going to replace Frank Gianotti. Further details with regards to the sale were not provided by Lotus Bio-Technology Development but it is a move that may prove to be of interest for many investors all the same. It may be a good idea for investors to perhaps add the stock to their watch lists and watch for movements.
Technical Data
LBTD stock is trading below the 20-Day and 50-Day Moving averages of $0.0388 and $0.0503 respectively. However, the stock is trading above the 200-Day moving average of $0.0242.
